Thursday, 20 Feb 2020

PsA/SpA

Date Typesort ascending Title Save
08 Feb 2016 Social Acute sacroiliitis Dx by bone or CT scan. Causes include pyogenic infx, brucellosis, crystal induced, neoplasia https://t.co/toLl8suM0i
20 Nov 2019 Social @uptoTate PLENARY: COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/mfTTMaCgWg #ACR19 Abst #2729 https://t.co/qaEi39JFPp
23 Oct 2016 Social Dr. Sergio Schwartzman comments on new Ocular Screening Guidlines for Hydroxychloroquine at RheumNow https://t.co/Qm1iDM77Jo
18 Jul 2017 Social 320 pt Rheum-Derm clinic in Vancouver - lupus is most common rheum dx; dermatitis & psoriasis most common Derm Dx https://t.co/soA3UXsfXF
07 Nov 2017 Social RT @Janetbirdope: #GAMECHANGER. Ankylosing spondylitis genetics are biased AS parent is more likely to have AS in sons #acr17 @rheumnow #1
14 Jun 2018 Social RT @DrPetryna: #EULAR18 @RheumNow ABST thu0297 CVRF higher in PSO, PsA & periph SpA w/o PSO comparing to gen pop but similar amongst the Dx…
17 Jun 2019 Social RT @tuna0sashimi: FUTURE 5 secukinumab in PsA placebo arm only 12w. Week 52 pt can increase doses from 150mg to 300mg. 2y data presented. S…
19 Feb 2018 Social 2018 AAD presentations on upadacitinib (Abbvies JAK1 inhibitor) shows it effective in reducine pruritus, with rapid responses in psoriasis by Week. Also under study for atopic dermatitis and more. https://t.co/6c4yauVPCC
04 Jan 2017 Social NICE recommends apremilast for use in psoriatic arthritis w/in UK NHS. Risk of suidical ideation is 0.2% (3/1441) https://t.co/ZFDSo3B81u
29 Sep 2017 Social Higher MASEI (enthesitis) scores in PsA assoc w/ more Jt damage, ankylosis, arthritis mutilans periostitis, axial Dz https://t.co/NKw37wkka5
07 Nov 2017 Social RT @Lupusdoc: Poster title of the day....! #2556 @RheumNow #ACR17 https://t.co/nDmsAQQS19
13 Jan 2019 Social QD Video on RheumNow - an HLA-B27+ patient with Iritis, Enthesitis, Diarrhea. https://t.co/LusZttdAyw
02 Jul 2015 Social Ixekizumab (anti-IL17) is superior to Enbrel in 1224 pts w/ plaque psoriasis (UNCOVER-2) w/ rapid decr in itch scores http://t.co/ozZbHEq6Wu
17 Feb 2017 Social RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow…
16 Oct 2017 Social Population survey found psoriasis/PsA in 1.4-3.3%; Nearly 1/2 not seeing MD or stopped biologic for safety/no effect https://t.co/JGHWuIUacK
08 Jun 2016 Social Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX
13 Feb 2020 Social 1st Jan inhibitor in AS - upadacitinib, it works! Drs Ruderman/Kavanaugh #RWCS2020 @RWCSmtg https://t.co/KLJh43h7pz
08 Nov 2017 Social RT @_connectedcare: Lots of different causes for Red Eye in autoimmune arthritis. Here’s a list #ACR17 @RheumNow https://t.co/pMi2tLMDpk
30 Sep 2019 Social Tofacitinib therapy is being studied (not yet approved) in several dermatologic conditions - psoriasis, alopecia areata/universalis, vitiligo, atopic dermatitis and dermatomyositis. https://t.co/Ez3u95Eh7K
11 Nov 2019 Social RT @EBRheum: RCT Tildrakizumab (IL23i) in Psoriatic Arthritis Beat PLBO for ACR20 (NNT~4), ACR50 (NNT~4), and pt global (NNT~3 for 50% imp…